Share Price and Basic Stock Data
Last Updated: November 28, 2025, 8:14 am
| PEG Ratio | -19.47 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Gujarat Fluorochemicals Ltd operates within the specialty chemicals sector, focusing on a diverse range of chemical products. As of March 2025, the company reported a market capitalization of ₹38,566 Cr, with its share price standing at ₹3,513. The company’s revenue from operations exhibited notable growth over recent years, increasing from ₹3,954 Cr in March 2022 to ₹5,685 Cr in March 2023. However, a decline to ₹4,281 Cr was observed in March 2024, followed by a recovery to ₹4,737 Cr in March 2025. This fluctuation highlights the volatility in revenue, which can be attributed to market dynamics and operational challenges. Quarterly sales figures also reflected this trend, with peaks of ₹1,471 Cr in March 2023, but a significant drop to ₹947 Cr in September 2023, followed by a gradual recovery. The company’s ability to navigate these revenue fluctuations will be crucial for its sustained growth in the competitive chemical sector.
Profitability and Efficiency Metrics
In terms of profitability, Gujarat Fluorochemicals reported a net profit of ₹680 Cr for the fiscal year ending March 2025, with a profit margin of 11.52%, which is relatively strong compared to typical sector margins. The operating profit margin (OPM) stood at 25.64%, indicating effective cost management despite fluctuations in sales. The quarterly operating profit showed significant variability, peaking at ₹536 Cr in September 2022 and falling to just ₹164 Cr in September 2023, demonstrating the impact of operational challenges. The interest coverage ratio (ICR) stood at a robust 8.27x, reflecting the company’s capability to cover interest expenses comfortably. However, with a return on equity (ROE) of 7.52% and return on capital employed (ROCE) of 10.63%, there is room for improvement in generating returns for shareholders. This highlights the need for strategic initiatives to enhance profitability and operational efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of Gujarat Fluorochemicals reflects a solid financial foundation, with total assets amounting to ₹10,602 Cr as of March 2025. Reserves have increased significantly to ₹7,242 Cr, indicating retained earnings and a commitment to reinvestment. The company’s borrowings stood at ₹2,080 Cr, resulting in a total debt-to-equity ratio of 0.27, which is favorable compared to industry standards, suggesting prudent leverage. Additionally, the current ratio of 1.70 and quick ratio of 0.97 indicate sufficient liquidity to meet short-term obligations. However, the cash conversion cycle (CCC) of 418 days points to potential inefficiencies in working capital management, particularly in inventory and receivables management. Enhancing these areas could further strengthen the balance sheet and improve cash flow dynamics.
Shareholding Pattern and Investor Confidence
The shareholding structure of Gujarat Fluorochemicals shows a stable promoter holding of 61.39% as of March 2025, reflecting strong insider confidence in the company’s prospects. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), hold 4.36% and 12.73% respectively, indicating moderate institutional interest. The public shareholding stands at 21.51%, with a total of 66,493 shareholders recorded. Over the past year, there has been a slight decrease in promoter and FII holdings, suggesting a cautious approach towards the stock amid market volatility. Nevertheless, the steady increase in DII ownership highlights growing institutional confidence in the company’s long-term potential. This mixed sentiment among shareholders could influence future stock performance and capital raising efforts.
Outlook, Risks, and Final Insight
The outlook for Gujarat Fluorochemicals hinges on its ability to stabilize revenue growth and enhance profitability metrics amidst operational challenges. The company faces risks including fluctuating raw material prices, which could impact margins, and potential regulatory changes affecting the chemicals sector. Additionally, the high cash conversion cycle indicates inefficiencies that need to be addressed. On the positive side, strengthening market demand for specialty chemicals presents opportunities for growth. The company’s solid balance sheet and liquidity position provide a buffer against short-term challenges, positioning it well for potential recovery. If management can effectively address operational inefficiencies and leverage market opportunities, Gujarat Fluorochemicals could see improved performance and shareholder value in the coming years.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Gujarat Fluorochemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 422 Cr. | 45.9 | 86.7/42.6 | 26.2 | 20.5 | 0.88 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 34.9 Cr. | 71.0 | 103/56.0 | 16.7 | 89.6 | 1.41 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 47.6 Cr. | 699 | 988/600 | 21.9 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,664 Cr. | 80.8 | 111/78.0 | 24.2 | 22.0 | 0.61 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 646 Cr. | 259 | 453/241 | 23.2 | 93.8 | 0.96 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,826.36 Cr | 735.46 | 63.36 | 183.02 | 0.43% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,334 | 1,461 | 1,418 | 1,471 | 1,209 | 947 | 992 | 1,133 | 1,176 | 1,188 | 1,148 | 1,225 | 1,281 |
| Expenses | 875 | 926 | 895 | 942 | 861 | 783 | 786 | 895 | 914 | 893 | 854 | 919 | 937 |
| Operating Profit | 459 | 536 | 523 | 529 | 348 | 164 | 206 | 238 | 262 | 295 | 294 | 306 | 344 |
| OPM % | 34% | 37% | 37% | 36% | 29% | 17% | 21% | 21% | 22% | 25% | 26% | 25% | 27% |
| Other Income | 26 | 24 | 21 | 19 | 15 | 13 | 13 | 18 | 9 | 9 | 14 | 26 | 23 |
| Interest | 21 | 23 | 38 | 35 | 28 | 34 | 37 | 34 | 37 | 42 | 42 | 26 | 30 |
| Depreciation | 55 | 57 | 60 | 64 | 66 | 68 | 72 | 81 | 85 | 90 | 91 | 89 | 90 |
| Profit before tax | 409 | 480 | 446 | 449 | 269 | 75 | 110 | 141 | 149 | 172 | 175 | 217 | 247 |
| Tax % | 26% | 26% | 26% | 26% | 25% | 29% | 27% | 28% | 28% | 30% | 28% | 12% | 26% |
| Net Profit | 303 | 357 | 331 | 332 | 201 | 53 | 80 | 101 | 108 | 121 | 126 | 191 | 184 |
| EPS in Rs | 27.88 | 32.88 | 29.99 | 30.21 | 18.30 | 4.82 | 7.28 | 9.19 | 9.83 | 11.02 | 11.47 | 17.39 | 16.75 |
Last Updated: August 20, 2025, 10:00 am
Below is a detailed analysis of the quarterly data for Gujarat Fluorochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,281.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,225.00 Cr. (Mar 2025) to 1,281.00 Cr., marking an increase of 56.00 Cr..
- For Expenses, as of Jun 2025, the value is 937.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 919.00 Cr. (Mar 2025) to 937.00 Cr., marking an increase of 18.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 344.00 Cr.. The value appears strong and on an upward trend. It has increased from 306.00 Cr. (Mar 2025) to 344.00 Cr., marking an increase of 38.00 Cr..
- For OPM %, as of Jun 2025, the value is 27.00%. The value appears strong and on an upward trend. It has increased from 25.00% (Mar 2025) to 27.00%, marking an increase of 2.00%.
- For Other Income, as of Jun 2025, the value is 23.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Mar 2025) to 23.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 4.00 Cr..
- For Depreciation, as of Jun 2025, the value is 90.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 89.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 247.00 Cr.. The value appears strong and on an upward trend. It has increased from 217.00 Cr. (Mar 2025) to 247.00 Cr., marking an increase of 30.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 12.00% (Mar 2025) to 26.00%, marking an increase of 14.00%.
- For Net Profit, as of Jun 2025, the value is 184.00 Cr.. The value appears to be declining and may need further review. It has decreased from 191.00 Cr. (Mar 2025) to 184.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 16.75. The value appears to be declining and may need further review. It has decreased from 17.39 (Mar 2025) to 16.75, marking a decrease of 0.64.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:17 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,851 | 2,729 | 2,606 | 2,650 | 3,954 | 5,685 | 4,281 | 4,737 | 4,864 |
| Expenses | 3,105 | 1,941 | 2,167 | 2,052 | 2,785 | 3,719 | 3,366 | 3,638 | 3,556 |
| Operating Profit | 745 | 788 | 439 | 598 | 1,168 | 1,965 | 915 | 1,100 | 1,308 |
| OPM % | 19% | 29% | 17% | 23% | 30% | 35% | 21% | 23% | 27% |
| Other Income | 112 | 78 | 190 | 199 | 161 | 172 | 100 | 115 | 69 |
| Interest | 279 | 56 | 105 | 113 | 78 | 117 | 133 | 147 | 131 |
| Depreciation | 299 | 164 | 192 | 202 | 205 | 236 | 286 | 355 | 361 |
| Profit before tax | 279 | 645 | 332 | 482 | 1,045 | 1,785 | 595 | 713 | 885 |
| Tax % | 14% | -93% | 43% | 146% | 26% | 26% | 27% | 23% | |
| Net Profit | 240 | 1,246 | 189 | -222 | 776 | 1,323 | 435 | 546 | 680 |
| EPS in Rs | 17.87 | -19.91 | 71.66 | 120.97 | 39.59 | 49.71 | 61.90 | ||
| Dividend Payout % | 15% | 0% | 0% | 0% | 6% | 3% | 8% | 6% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 419.17% | -84.83% | -217.46% | 449.55% | 70.49% | -67.12% | 25.52% |
| Change in YoY Net Profit Growth (%) | 0.00% | -504.00% | -132.63% | 667.01% | -379.06% | -137.61% | 92.64% |
Gujarat Fluorochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 6% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | -11% |
| TTM: | 82% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 0% |
| 1 Year: | -4% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 13% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 5:35 am
Balance Sheet
Last Updated: October 10, 2025, 2:08 pm
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 4,756 | 3,499 | 3,705 | 3,482 | 4,244 | 5,510 | 5,925 | 7,242 |
| Borrowings | 2,000 | 968 | 1,718 | 1,581 | 1,556 | 1,515 | 2,096 | 2,080 |
| Other Liabilities | 2,986 | 441 | 634 | 895 | 1,067 | 1,335 | 1,201 | 1,270 |
| Total Liabilities | 9,753 | 4,919 | 6,067 | 5,969 | 6,878 | 8,371 | 9,233 | 10,602 |
| Fixed Assets | 3,813 | 2,305 | 2,414 | 2,367 | 2,514 | 3,111 | 4,264 | 4,285 |
| CWIP | 724 | 229 | 318 | 400 | 680 | 1,158 | 1,128 | 1,568 |
| Investments | 524 | 342 | 259 | 88 | 20 | 1 | 1 | 289 |
| Other Assets | 4,691 | 2,042 | 3,076 | 3,114 | 3,665 | 4,101 | 3,840 | 4,460 |
| Total Assets | 9,753 | 4,919 | 6,067 | 5,969 | 6,878 | 8,371 | 9,233 | 10,602 |
Below is a detailed analysis of the balance sheet data for Gujarat Fluorochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
- For Reserves, as of Mar 2025, the value is 7,242.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,925.00 Cr. (Mar 2024) to 7,242.00 Cr., marking an increase of 1,317.00 Cr..
- For Borrowings, as of Mar 2025, the value is 2,080.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,096.00 Cr. (Mar 2024) to 2,080.00 Cr., marking a decrease of 16.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1,270.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,201.00 Cr. (Mar 2024) to 1,270.00 Cr., marking an increase of 69.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 10,602.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,233.00 Cr. (Mar 2024) to 10,602.00 Cr., marking an increase of 1,369.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 4,285.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,264.00 Cr. (Mar 2024) to 4,285.00 Cr., marking an increase of 21.00 Cr..
- For CWIP, as of Mar 2025, the value is 1,568.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,128.00 Cr. (Mar 2024) to 1,568.00 Cr., marking an increase of 440.00 Cr..
- For Investments, as of Mar 2025, the value is 289.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 289.00 Cr., marking an increase of 288.00 Cr..
- For Other Assets, as of Mar 2025, the value is 4,460.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,840.00 Cr. (Mar 2024) to 4,460.00 Cr., marking an increase of 620.00 Cr..
- For Total Assets, as of Mar 2025, the value is 10,602.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,233.00 Cr. (Mar 2024) to 10,602.00 Cr., marking an increase of 1,369.00 Cr..
Notably, the Reserves (7,242.00 Cr.) exceed the Borrowings (2,080.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 743.00 | -180.00 | 438.00 | 597.00 | 0.00 | 0.00 | 913.00 | -1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 184 | 77 | 79 | 92 | 72 | 71 | 72 | 92 |
| Inventory Days | 736 | 351 | 390 | 404 | 314 | 375 | 435 | 487 |
| Days Payable | 471 | 127 | 176 | 159 | 170 | 174 | 144 | 162 |
| Cash Conversion Cycle | 449 | 301 | 293 | 338 | 216 | 272 | 363 | 418 |
| Working Capital Days | 67 | 22 | -0 | 6 | 33 | 62 | 60 | 97 |
| ROCE % | 11% | 9% | 11% | 20% | 30% | 10% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Mid-Cap Opportunities Fund - Regular Plan | 1,990,000 | 1.09 | 567.38 | 1,990,000 | 2025-04-22 13:31:13 | 0% |
| Mirae Asset Focused Fund | 806,119 | 2.53 | 229.84 | 806,119 | 2025-04-22 17:25:34 | 0% |
| DSP Flexi Cap Fund | 762,208 | 2.3 | 217.32 | 762,208 | 2025-04-22 17:25:34 | 0% |
| DSP Equity & Bond Fund | 528,892 | 1.79 | 150.8 | 528,892 | 2025-04-22 17:25:34 | 0% |
| Aditya Birla Sun Life Midcap Fund | 457,307 | 2.82 | 130.39 | 457,307 | 2025-04-22 15:56:57 | 0% |
| DSP ELSS Tax Saver Fund | 435,648 | 0.98 | 124.21 | 435,648 | 2025-04-22 17:25:34 | 0% |
| DSP Equity Opportunities Fund | 389,579 | 1.15 | 111.07 | 389,579 | 2025-04-22 17:25:34 | 0% |
| Nippon India Growth Fund | 374,595 | 0.5 | 106.8 | 374,595 | 2025-04-22 17:25:34 | 0% |
| Nippon India Small Cap Fund | 281,735 | 0.2 | 80.33 | 281,735 | 2025-04-22 17:25:34 | 0% |
| Aditya Birla Sun Life Flexi Cap Fund | 281,258 | 0.44 | 80.19 | 281,258 | 2025-04-22 17:25:34 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 49.69 | 39.60 | 120.44 | 70.63 | -20.17 |
| Diluted EPS (Rs.) | 49.69 | 39.60 | 120.44 | 70.63 | -20.17 |
| Cash EPS (Rs.) | 81.91 | 65.64 | 141.93 | 89.33 | -1.77 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 659.36 | 540.40 | 502.57 | 385.10 | 316.70 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 659.36 | 540.40 | 502.57 | 385.10 | 316.70 |
| Revenue From Operations / Share (Rs.) | 430.64 | 389.70 | 517.49 | 359.91 | 241.28 |
| PBDIT / Share (Rs.) | 110.45 | 92.33 | 194.59 | 120.99 | 72.55 |
| PBIT / Share (Rs.) | 78.18 | 66.29 | 173.10 | 102.28 | 54.16 |
| PBT / Share (Rs.) | 64.82 | 54.17 | 162.47 | 95.15 | 43.91 |
| Net Profit / Share (Rs.) | 49.64 | 39.60 | 120.44 | 70.63 | -20.17 |
| NP After MI And SOA / Share (Rs.) | 49.64 | 39.60 | 120.97 | 71.66 | -19.91 |
| PBDIT Margin (%) | 25.64 | 23.69 | 37.60 | 33.61 | 30.06 |
| PBIT Margin (%) | 18.15 | 17.01 | 33.45 | 28.41 | 22.44 |
| PBT Margin (%) | 15.05 | 13.90 | 31.39 | 26.43 | 18.19 |
| Net Profit Margin (%) | 11.52 | 10.16 | 23.27 | 19.62 | -8.35 |
| NP After MI And SOA Margin (%) | 11.52 | 10.16 | 23.37 | 19.91 | -8.25 |
| Return on Networth / Equity (%) | 7.52 | 7.32 | 24.06 | 18.49 | -6.26 |
| Return on Capital Employeed (%) | 10.63 | 10.81 | 31.52 | 22.60 | 14.23 |
| Return On Assets (%) | 5.14 | 4.71 | 15.87 | 11.44 | -3.66 |
| Long Term Debt / Equity (X) | 0.05 | 0.06 | 0.03 | 0.10 | 0.11 |
| Total Debt / Equity (X) | 0.27 | 0.33 | 0.26 | 0.36 | 0.40 |
| Asset Turnover Ratio (%) | 0.47 | 0.48 | 0.74 | 0.59 | 0.42 |
| Current Ratio (X) | 1.70 | 1.36 | 1.50 | 1.28 | 1.08 |
| Quick Ratio (X) | 0.97 | 0.73 | 0.86 | 0.78 | 0.59 |
| Inventory Turnover Ratio (X) | 0.98 | 1.52 | 2.61 | 2.28 | 1.73 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 5.05 | 3.30 | 2.79 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 3.04 | 2.80 | 2.21 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 94.95 | 96.70 | 97.21 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 96.96 | 97.20 | 97.79 | 0.00 |
| Interest Coverage Ratio (X) | 8.27 | 7.62 | 18.30 | 16.95 | 7.08 |
| Interest Coverage Ratio (Post Tax) (X) | 4.71 | 4.27 | 12.33 | 10.90 | -0.96 |
| Enterprise Value (Cr.) | 46047.40 | 35822.28 | 34443.07 | 31565.58 | 7693.95 |
| EV / Net Operating Revenue (X) | 9.72 | 8.37 | 6.06 | 7.98 | 2.90 |
| EV / EBITDA (X) | 37.90 | 35.32 | 16.11 | 23.75 | 9.65 |
| MarketCap / Net Operating Revenue (X) | 9.34 | 7.95 | 5.83 | 7.64 | 2.38 |
| Retention Ratios (%) | 0.00 | 94.94 | 96.69 | 97.20 | 0.00 |
| Price / BV (X) | 6.10 | 5.73 | 6.00 | 7.10 | 1.81 |
| Price / Net Operating Revenue (X) | 9.34 | 7.95 | 5.83 | 7.64 | 2.38 |
| EarningsYield | 0.01 | 0.01 | 0.04 | 0.02 | -0.03 |
After reviewing the key financial ratios for Gujarat Fluorochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 49.69. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.69, marking an increase of 10.09.
- For Diluted EPS (Rs.), as of Mar 25, the value is 49.69. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.69, marking an increase of 10.09.
- For Cash EPS (Rs.), as of Mar 25, the value is 81.91. This value is within the healthy range. It has increased from 65.64 (Mar 24) to 81.91, marking an increase of 16.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 659.36. It has increased from 540.40 (Mar 24) to 659.36, marking an increase of 118.96.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 659.36. It has increased from 540.40 (Mar 24) to 659.36, marking an increase of 118.96.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 430.64. It has increased from 389.70 (Mar 24) to 430.64, marking an increase of 40.94.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 110.45. This value is within the healthy range. It has increased from 92.33 (Mar 24) to 110.45, marking an increase of 18.12.
- For PBIT / Share (Rs.), as of Mar 25, the value is 78.18. This value is within the healthy range. It has increased from 66.29 (Mar 24) to 78.18, marking an increase of 11.89.
- For PBT / Share (Rs.), as of Mar 25, the value is 64.82. This value is within the healthy range. It has increased from 54.17 (Mar 24) to 64.82, marking an increase of 10.65.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 49.64. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.64, marking an increase of 10.04.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 49.64. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.64, marking an increase of 10.04.
- For PBDIT Margin (%), as of Mar 25, the value is 25.64. This value is within the healthy range. It has increased from 23.69 (Mar 24) to 25.64, marking an increase of 1.95.
- For PBIT Margin (%), as of Mar 25, the value is 18.15. This value is within the healthy range. It has increased from 17.01 (Mar 24) to 18.15, marking an increase of 1.14.
- For PBT Margin (%), as of Mar 25, the value is 15.05. This value is within the healthy range. It has increased from 13.90 (Mar 24) to 15.05, marking an increase of 1.15.
- For Net Profit Margin (%), as of Mar 25, the value is 11.52. This value exceeds the healthy maximum of 10. It has increased from 10.16 (Mar 24) to 11.52, marking an increase of 1.36.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.52. This value is within the healthy range. It has increased from 10.16 (Mar 24) to 11.52, marking an increase of 1.36.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.52. This value is below the healthy minimum of 15. It has increased from 7.32 (Mar 24) to 7.52, marking an increase of 0.20.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.63. This value is within the healthy range. It has decreased from 10.81 (Mar 24) to 10.63, marking a decrease of 0.18.
- For Return On Assets (%), as of Mar 25, the value is 5.14. This value is within the healthy range. It has increased from 4.71 (Mar 24) to 5.14, marking an increase of 0.43.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.27, marking a decrease of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has decreased from 0.48 (Mar 24) to 0.47, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.36 (Mar 24) to 1.70, marking an increase of 0.34.
- For Quick Ratio (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 24) to 0.97, marking an increase of 0.24.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 4. It has decreased from 1.52 (Mar 24) to 0.98, marking a decrease of 0.54.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.05 (Mar 24) to 0.00, marking a decrease of 5.05.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.04 (Mar 24) to 0.00, marking a decrease of 3.04.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.95 (Mar 24) to 0.00, marking a decrease of 94.95.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.96 (Mar 24) to 0.00, marking a decrease of 96.96.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.27. This value is within the healthy range. It has increased from 7.62 (Mar 24) to 8.27, marking an increase of 0.65.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.71. This value is within the healthy range. It has increased from 4.27 (Mar 24) to 4.71, marking an increase of 0.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 46,047.40. It has increased from 35,822.28 (Mar 24) to 46,047.40, marking an increase of 10,225.12.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.72. This value exceeds the healthy maximum of 3. It has increased from 8.37 (Mar 24) to 9.72, marking an increase of 1.35.
- For EV / EBITDA (X), as of Mar 25, the value is 37.90. This value exceeds the healthy maximum of 15. It has increased from 35.32 (Mar 24) to 37.90, marking an increase of 2.58.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.34. This value exceeds the healthy maximum of 3. It has increased from 7.95 (Mar 24) to 9.34, marking an increase of 1.39.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 94.94 (Mar 24) to 0.00, marking a decrease of 94.94.
- For Price / BV (X), as of Mar 25, the value is 6.10. This value exceeds the healthy maximum of 3. It has increased from 5.73 (Mar 24) to 6.10, marking an increase of 0.37.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.34. This value exceeds the healthy maximum of 3. It has increased from 7.95 (Mar 24) to 9.34, marking an increase of 1.39.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Fluorochemicals Ltd:
- Net Profit Margin: 11.52%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.63% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.52% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.97
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 56.2 (Industry average Stock P/E: 63.36)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.27
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.52%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Survey No 16/3, 26 and 27, Village Ranjitnagar, Panchmahal District Gujarat 389380 | bvdesai@gfl.co.in http://www.gfl.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Devendra Kumar Jain | Chairman & Non Independent Director |
| Mr. Vivek Kumar Jain | Managing Director |
| Dr. Bir Kapoor | Deputy Managing Director |
| Mr. Sanath Kumar Muppirala | Whole Time Director |
| Mr. Niraj Agnihotri | Whole Time Director |
| Mr. Shanti Prashad Jain | Independent Director |
| Mr. Shailendra Swarup | Independent Director |
| Mr. Om Prakash Lohia | Independent Director |
| Mr. Chandra Prakash Jain | Independent Director |
| Ms. Vanita Bhargava | Independent Director |
FAQ
What is the intrinsic value of Gujarat Fluorochemicals Ltd?
Gujarat Fluorochemicals Ltd's intrinsic value (as of 29 November 2025) is 2585.26 which is 25.65% lower the current market price of 3,477.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 38,194 Cr. market cap, FY2025-2026 high/low of 4,535/3,100, reserves of ₹7,242 Cr, and liabilities of 10,602 Cr.
What is the Market Cap of Gujarat Fluorochemicals Ltd?
The Market Cap of Gujarat Fluorochemicals Ltd is 38,194 Cr..
What is the current Stock Price of Gujarat Fluorochemicals Ltd as on 29 November 2025?
The current stock price of Gujarat Fluorochemicals Ltd as on 29 November 2025 is 3,477.
What is the High / Low of Gujarat Fluorochemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gujarat Fluorochemicals Ltd stocks is 4,535/3,100.
What is the Stock P/E of Gujarat Fluorochemicals Ltd?
The Stock P/E of Gujarat Fluorochemicals Ltd is 56.2.
What is the Book Value of Gujarat Fluorochemicals Ltd?
The Book Value of Gujarat Fluorochemicals Ltd is 693.
What is the Dividend Yield of Gujarat Fluorochemicals Ltd?
The Dividend Yield of Gujarat Fluorochemicals Ltd is 0.09 %.
What is the ROCE of Gujarat Fluorochemicals Ltd?
The ROCE of Gujarat Fluorochemicals Ltd is 9.89 %.
What is the ROE of Gujarat Fluorochemicals Ltd?
The ROE of Gujarat Fluorochemicals Ltd is 8.29 %.
What is the Face Value of Gujarat Fluorochemicals Ltd?
The Face Value of Gujarat Fluorochemicals Ltd is 1.00.